TIAA CREF INVESTMENT MANAGEMENT LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q1 2019$3,942,000
-23.8%
84,655
-28.8%
0.00%
-25.0%
Q4 2018$5,175,000
-62.6%
118,830
-50.8%
0.00%
-20.0%
Q3 2018$13,824,000
+177.1%
241,568
+135.0%
0.01%
+66.7%
Q2 2018$4,988,000
+47.0%
102,798
+18.4%
0.00%
+50.0%
Q1 2018$3,394,000
-8.1%
86,811
-0.2%
0.00%0.0%
Q4 2017$3,693,000
+18.0%
87,027
+3.8%
0.00%0.0%
Q3 2017$3,129,000
+19.4%
83,849
-2.7%
0.00%0.0%
Q2 2017$2,620,000
+0.2%
86,211
-12.7%
0.00%0.0%
Q1 2017$2,614,000
+30.4%
98,743
+25.7%
0.00%
+100.0%
Q4 2016$2,005,000
-33.8%
78,554
-6.1%
0.00%
-50.0%
Q3 2016$3,029,000
-11.0%
83,696
-16.5%
0.00%
-33.3%
Q2 2016$3,405,000
+44.0%
100,192
+11.8%
0.00%
+50.0%
Q1 2016$2,364,000
-30.1%
89,587
+29.2%
0.00%
-33.3%
Q4 2015$3,380,000
+90.3%
69,324
-2.8%
0.00%
+200.0%
Q3 2015$1,776,000
-23.2%
71,333
-2.4%
0.00%
-50.0%
Q2 2015$2,312,000
+5.8%
73,059
+27.3%
0.00%0.0%
Q1 2015$2,185,000
-2.3%
57,4060.0%0.00%0.0%
Q4 2014$2,237,000
+22.9%
57,406
-4.6%
0.00%
+100.0%
Q3 2014$1,820,000
-27.1%
60,188
-18.1%
0.00%
-50.0%
Q2 2014$2,497,000
+94.9%
73,515
+97.9%
0.00%
+100.0%
Q1 2014$1,281,000
-34.1%
37,141
-24.3%
0.00%0.0%
Q4 2013$1,943,00049,0700.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders